EUVIMEDEUVIMED entdecken
Crossref

Vitexin inhibits renal cell carcinoma progression by targeting Galectin-1-mediated glycolytic metabolism

Xinjun Wang, Yue Bu, Zhangqun Li, Qian Zong, Xuqiang Wang, Bin Zhou, Guangcheng Luo

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-11928-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 11.05.2026. Verfasst von Xinjun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Apigenin, Galectin 1, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Natural Science Foundation of Xiamen Municipality, Science and Technology Program for High-Quality Health Development of Xiamen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApigeninGalectin 1Carcinoma, Renal CellKidney NeoplasmsHumansAnimalsGlycolysisCell Line, TumorMiceCell ProliferationMice, NudeApoptosisGene Expression Regulation, NeoplasticSignal TransductionXenograft Model Antitumor AssaysCell MovementCell SurvivalDisease ProgressionMetabolic Reprogramming

Stichwörter der Autor:innen

Galectin-1Glycolytic metabolismRenal cell carcinomaTumor suppressionVitexin

Substanzen

ApigeninGalectin 1vitexin

Autor:innen und Institutionen

  • Department of Urology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • The Graduate School of Fujian Medical University, Fuzhou, China.
  • Department of Urology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, China. lgch@xmu.edu.cn.
  • The Graduate School of Fujian Medical University, Fuzhou, China. lgch@xmu.edu.cn.

Förderung

  • Natural Science Foundation of Fujian Province
  • Natural Science Foundation of Xiamen Municipality
  • Science and Technology Program for High-Quality Health Development of Xiamen

Zitieren

APA

Wang, X., Bu, Y., Li, Z., Zong, Q., Wang, X., Zhou, B., & Luo, G. (2026). Vitexin inhibits renal cell carcinoma progression by targeting Galectin-1-mediated glycolytic metabolism. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-11928-2

Vancouver

Wang X, Bu Y, Li Z, Zong Q, Wang X, Zhou B, et al. Vitexin inhibits renal cell carcinoma progression by targeting Galectin-1-mediated glycolytic metabolism. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-11928-2

BibTeX
@article{Wang2026,
  author = {Wang, Xinjun and Bu, Yue and Li, Zhangqun and Zong, Qian and Wang, Xuqiang and Zhou, Bin and Luo, Guangcheng},
  title = {Vitexin inhibits renal cell carcinoma progression by targeting Galectin-1-mediated glycolytic metabolism},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-11928-2}
}
Kostenlos starten →